Chief Financial Officer Robin Kramer explained how the deal not only provides two marketed products, but a team with nephrology expertise that will be valuable as Biogen prepares to launch felzartamab ...
Every bit of zinc counts, especially for people eating a mostly plant-based diet, dietitians say. These fruits contain the ...
Acquisition will bring two differentiated commercialized immunology medicines to Biogen with EMPAVELI® FDA-approved in three indications, ...
Considering the debt-to-equity ratio in industry comparisons allows for a concise evaluation of a company's financial health and risk profile, aiding in informed decision-making.
Scientists have uncovered an important new link between the brain and immune system after stroke, which could lead to ...
Dealbreaker on MSN
Why Biogen is paying $5.6B to buy Apellis Pharma
CEO Chris Viehbacher said Apellis accelerates Biogen’s expansion in nephrology, supporting a HI-Bio drug currently in pivotal ...
A fragrance expert reveals scent's profound impact on attraction, with nearly half of singles noting its influence on date ...
Immunoglobulin A (IgA) nephropathy results from the accumulation of IgA-containing immune complexes (IgA-ICs) and aberrant ...
A new deep-brain BCI from Tsinghua University uses the lateral ventricles to record neural signals. This "lantern" electrode ...
Explore how human-relevant tumor models like 3D cultures, organoids, organ-on-chip platforms, and the 3MIC system are ...
In this Point of View column,, CEO of Taconic Biosciences, explores redefining preclinical models for the future of drug development.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results